YUBO INTERNATIONAL BIOTECH LIMITED Net Change in Cash
YUBO INTERNATIONAL BIOTECH LIMITED (YBGJ) reported Net Change in Cash of $3.93 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-14
- YUBO INTERNATIONAL BIOTECH LIMITED cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was $2.32K, a 15.88% decline year-over-year.
- YUBO INTERNATIONAL BIOTECH LIMITED cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was $2.76K, a 94.56% decline year-over-year.
- YUBO INTERNATIONAL BIOTECH LIMITED cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was $50.66K, a 321.86% increase year-over-year.
- YUBO INTERNATIONAL BIOTECH LIMITED cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was $12.01K.
- YUBO INTERNATIONAL BIOTECH LIMITED cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was $1.05K, a 59.60% increase from fiscal 2024.
- YUBO INTERNATIONAL BIOTECH LIMITED cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was $656.00.
- YUBO INTERNATIONAL BIOTECH LIMITED cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was -$11.86K.
- YUBO INTERNATIONAL BIOTECH LIMITED cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$9.30K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $3.93K 10-Q · filed 2026-08-14 | ||||
| 2026-03-31 | $2.32K 10-Q · filed 2026-05-15 | ||||
| 2025-12-31 | $1.05K 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | $3.91K 10-Q · filed 2025-11-14 | ||||
| 2025-06-30 | $3.40K 10-Q · filed 2026-08-14 | ||||
| 2025-03-31 | $2.76K 10-Q · filed 2026-05-15 | ||||
| 2024-12-31 | $656.00 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | $1.68K 10-Q · filed 2025-11-14 | ||||
| 2024-06-30 | $6.36K 10-Q · filed 2025-08-13 | $1.34K 10-Q · filed 2024-08-19 | |||
| 2024-03-31 | $50.66K 10-Q · filed 2025-05-14 | ||||
| 2023-12-31 | -$11.86K 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$12.93K 10-Q · filed 2024-11-13 | ||||
| 2023-06-30 | -$13.02K 10-Q · filed 2024-08-19 | -$12.92K 10-Q · filed 2023-08-11 | |||
| 2023-03-31 | $12.01K 10-Q · filed 2024-05-20 | ||||
| 2022-12-31 | -$9.30K 10-K · filed 2024-04-12 | ||||
| 2022-09-30 | $62.45K 10-Q · filed 2023-11-20 | ||||
| 2022-06-30 | $9.06K 10-Q · filed 2023-08-11 | ||||
| 2022-03-31 | -$17.08K 10-Q · filed 2023-05-15 | ||||
| 2021-12-31 | -$1.36M 10-K · filed 2023-04-14 | ||||
| 2021-09-30 | -$1.32M 10-Q · filed 2022-11-16 | ||||
| 2021-06-30 | -$1.30M 10-Q · filed 2022-08-15 | ||||
| 2021-03-31 | -$1.26M 10-Q · filed 2022-05-16 | ||||
| 2020-12-31 | $1.38M 10-K · filed 2022-04-15 |